Back to Invesco Ltd. Invesco Ltd.

KNSAKNSA
8 quarters

Position history for Invesco Ltd.Invesco Ltd.'s holdings in KINIKSA PHARMACEUTICALS INTE

Yes. Invesco holds 772,806 shares of KNSA (Kiniksa Pharmaceuticals Inte), worth $49.4M, as of its Q2 2026 13F filing. It increased the position from 27,656 shares in Q1 2026. Invesco has held KNSA since Q3 2024, across 8 quarterly 13F filings.

Current Value

$49.4M

Current Shares

772,806

Total Value Change

+$48M

Total Shares Change

+717,318

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
772,806
+2694.3%
$49.4M0.0%$63.95
47
2026-Q1
Decreased
27,656
-14.5%
$1.3M0.0%$48.15
0
2025-Q4
Increased
32,334
+25.9%
$1.3M0.0%$41.25
31
2025-Q3
Increased
25,678
+26.6%
$997,0760.0%$38.83
31
2025-Q2
Decreased
20,289
-39.4%
$561,3970.0%$27.67
0
2025-Q1
Increased
33,492
+137.4%
$743,8570.0%$22.21
40
2024-Q4
Decreased
14,108
-74.6%
$279,0570.0%$19.78
0
2024-Q3
New
55,488
-
$1.4M0.0%$24.99
35

Other major holders of KNSA: FMR LLC, BAKER BROS. ADVISORS LP, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used